Claims
- 1. A method of treating healed wounds so as to prevent or reduce scarring and/or improve the appearance of scars comprises; applying onto a healed wound a composition comprising a fluid, film-forming carrier, and subsequently hardening the carrier into a tangible membrane juxtaposed to the healed wound thereby reducing scarring or improving the appearance thereof.
- 2. The method of claim 1, wherein the film-forming carrier comprises Collodion or Flexible Collodion.
- 3. The method of claim 1, wherein said composition is applied onto the healed wound by brushing, rolling, extruding or applying drops of said composition.
- 4. The method of claim 3, wherein said composition is applied to the healed wound by brushing.
- 5. The method of claim 1, wherein said composition includes an active ingredient capable of reducing scarring or improving the appearance of scars selected from a topical steroid, silicone-gel, vitamin and mixtures thereof.
- 6. The method of claim 5, wherein said active ingredient includes a corticosteroid or a pharmaceutically acceptable salt thereof.
- 7. The method of claim 5, wherein said active ingredient comprises a combination of a topical steroid and silicone-gel.
- 8. The method of claim 5, wherein said active ingredient is a silicone-gel.
- 9. The method of claim 7, wherein said composition further includes vitamin E.
- 10. The method of claim 1, wherein said film-forming carrier is a cellulosic derivative.
- 11. The method of claim 10, wherein said cellulosic derivative is nitrocellulose.
- 12. The method of claim 10, wherein said cellulosic derivative is methyl cellulose.
- 13. The method of claim 1, wherein said film-forming carrier comprises a silicone resin.
- 14. The method of claim 1, wherein said healed wound comprises a hypertrophic scar.
- 15. The method of claim 1, wherein said healed wound is one formed after surgery.
- 16. The method of claim 1, wherein said healed wound is formed after accidental trauma.
- 17. A method of treating immunological skin disorders comprising applying onto an area of skin affected by said skin disorder a fluid, film-forming carrier having contained therein a steroid, and hardening the carrier into a tangible, membrane juxtaposed to said affected area.
- 18. The method of claim 17, wherein said skin disorder is eczema, psoriasis, or atopic dermatitis.
- 19. A composition for treating adverse skin conditions comprising a fluid, film-forming carrier and an active ingredient comprising a topically active steroid or, a silicone-gel or mixture thereof, said carrier capable of hardening to a tangible membrane.
- 20. The composition of claim 19, wherein said active ingredient is a topically active steroid comprising at least one corticosteroid or a pharmaceutically acceptable salt thereof.
- 21. The composition of claim 19, wherein said active ingredient is a silicone-gel.
- 22. The composition of claim 21, wherein said silicone-gel is phenyltrimethicone.
- 23. The composition of claim 19, wherein said active ingredient comprises a mixture of said steroid and silicone-gel.
- 24. The composition of claim 19, wherein said active ingredient further contains a vitamin.
- 25. The composition of claim 23, wherein said active ingredient comprises a mixture of said topical steroid, a silicone-gel, and optionally, vitamin E.
- 26. The composition of claim 19, wherein said film-forming carrier comprises a cellulosic derivative.
- 27. The composition of claim 26, wherein said cellulosic derivative is nitrocellulose
- 28. The composition of claim 25, wherein said film-forming carrier comprises nitrocellulose.
- 29. The composition of claim 26, wherein said cellulosic derivative is methylcelluose.
- 30. A method of treating healed wounds so as to prevent or reduce scarring and/or improve the appearance of scars comprises:
applying onto a healed wound a topical composition comprising collagenase.
- 31. The method of claim 30, wherein said topical composition comprises collagenase contained within a fluid, film-forming carrier, subsequent to applying said composition onto said healed wound, hardening said carrier into a tangible membrane juxtaposed to the healed wound.
- 32. The method of claim 30, wherein said topical composition comprises collagenase contained within a topical creme, ointment, lotion or gel.
- 33. A method of administering an analgesic comprising mixing an analgesic within a fluid, film-forming carrier, applying said mixture as a fluid onto the skin, whereby said film-forming carrier containing said analgesic hardens to a tangible membrane juxtaposed to the skin surface.
- 34. The method of claim 33, wherein said analgesic is a topical anesthetic.
- 35. The method of claim 33, wherein said analgesic is transdermally administered parenterally.
- 36. A method of treating cancer comprising mixing a chemotherapeutic agent into a fluid, film-forming carrier to form a mixture, applying said mixture as a fluid onto the skin surface, said carrier containing said chemotherapeutic agent hardening into a tangible membrane juxtaposed to said skin surface.
- 37. The method of claim 36, wherein said cancer is a skin cancer and said mixture is applied topically thereto.
- 38. The method of claim 36, wherein said cancer is contained within internal tissues and said chemotherapeutic agent is transdermally administered subsequent to formation of said membrane.
- 39. A method of providing an internal physiological effect to a mammal comprising mixing an active ingredient having an internal physiological effect with a film-forming carrier to form a fluid mixture, applying said fluid mixture to the skin of said mammal, said fluid, film-forming carrier containing said active ingredient hardening to a tangible membrane juxtaposed to the skin whereby said active ingredient can be transdermally administered to internal tissue.
- 40. The method of claim 39, wherein said active ingredient is a vasodilator.
- 41. The method of claim 39, wherein said active ingredient suppresses drug-addictive cravings.
- 42. The method of claim 41, wherein said active ingredient is nicotine.
- 43. The method of claim 39, wherein said active ingredient is a bronchial dilator.
- 44. The method of claim 39, wherein said active ingredient is an antihistamine.
- 45. The method of claim 44, wherein said antihistamine is benadryl.
- 46. A composition comprising a topically effective anesthetic mixed within a fluid, film-forming carrier, said carrier capable of hardening to a tangible membrane juxtaposed to the topical site of application.
- 47. A composition comprising an active ingredient having an internal physiological effect on a mammal mixed within a fluid, film-forming carrier, said carrier capable of hardening to a tangible membrane juxtaposed to the topical site of application.
- 48. The composition of claim 47, wherein said active ingredient is nicotine.
- 49. The composition of claim 47, wherein said active ingredient is vasodilator.
- 50. The composition of claim 47, wherein said active ingredient suppresses drug-addictive cravings.
- 51. The composition of claim 47, wherein said active ingredient is a bronchial dilator.
- 52. The composition of claim 47, wherein said active ingredient is an antihistamine.
- 53. The composition of claim 52, wherein said antihistamine is benadryl.
- 54. The composition of claim 47, wherein said active ingredient is an opioid.
RELATED PATENTS AND APPLICATIONS
[0001] This application is a continuation-in-part of U.S. Ser. No. 09/441,138, filed Nov. 17, 1999.
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
09441138 |
Nov 1999 |
US |
Child |
10022216 |
Dec 2001 |
US |